本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ORUKA THERAPEUTICS INC

92.38
+0.73000.80%
成交量:58.53萬
成交額:5,397.86萬
市值:61.16億
市盈率:-45.64
高:94.29
開:93.40
低:90.48
收:91.65
52周最高:115.52
52周最低:14.67
股本:6,620.97萬
流通股本:5,688.40萬
量比:0.89
換手率:1.03%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
淨資產收益率:-18.23%
總資產收益率:-12.95%
市淨率:5.50
市盈率(LYR):-49.98

資料載入中...

2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

重要事件披露

Form 8-K - Current report
2026/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]